Zubair, S., Hafeez, S., & Mujtaba, G
For self-pay patients, the Wegovy pill starter dose at ~$149/month (promotional pricing through April 2026) offers the lowest entry point
An expert panel suggests it may be most helpful in patients with mild cases of high cholesterol who do not tolerate statin drugs or who have metabolic syndrome
No increase in number of adverse events with increasing renal or hepatic impairment was observed, and no new safety or tolerability findings with cagrilintide were identified with renal or hepatic impairment
However, this adaptive mechanism may not be sufficient to counteract the overwhelming oxidative burden caused by iron overload (83)
Consult with your provider if youve experienced pancreatitis or have severe gastrointestinal issues to explore other effective weight management alternatives